Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pericoital Levonorgestrel Contraception Study
NCT00922233Phase 3Completed
- Sponsor
- FHI 360
- Start
- Jan 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of avatrombopag in pregnancy, sponsored by FHI 360. Primary endpoints: Pearl Index (Number of Pregnancies Per 100 Woman-years) at 6.5 months and Participant Report of Adverse Events at 6.5 months. Started Jan 2010; status: completed.
02
Drugs
avatrombopag
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00922233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00922233.